Archive - January 2020
U.S. FDA Acknowledges Receipt of Evofem Biosciences’ New Drug Application Resubmission for Amphora for the Prevention of Pregnancy
MacroGenics Announces Submission of Margetuximab Biologics License Application to U.S. FDA
FibroGen Submits New Drug Application to the U.S. FDA for Roxadustat in Patients With Anemia of Chronic Kidney Disease
Zosano Announces FDA Submission of New Drug Application for Qtrypta
Immunomedics Announces FDA Acceptance for Filing of Biologics License Application Resubmission for Sacituzumab Govitecan to Treat Metastatic Triple-Negative Breast Cancer
Urovant Sciences Announces Submission of New Drug Application for Vibegron for the Treatment of Overactive Bladder
Chiasma Announces FDA Acceptance of Mycapssa New Drug Application Resubmission
Nektar Issues Statement Regarding FDA Advisory Committee Vote for Oxycodegol
